Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
NVCR

Novocure

$52.05

3.05 (6.22%)

16:51
09/19/18
09/19
16:51
09/19/18
16:51
Conference/Events
Novocure management to meet with Evercore ISI »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

NVCR

Novocure

$49.00

2.625 (5.66%)

06:34
09/19/18
09/19
06:34
09/19/18
06:34
Recommendations
Novocure analyst commentary at Wells Fargo »

Novocure price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
NVCR

Novocure

$45.05

-0.15 (-0.33%)

, ZLAB

Zai Lab

$18.33

0.47 (2.63%)

07:34
09/12/18
09/12
07:34
09/12/18
07:34
Hot Stocks
Novocure, Zai Lab announce strategic collaboration for Tumor Treating Fields »

Novocure (NVCR) and Zai…

NVCR

Novocure

$45.05

-0.15 (-0.33%)

ZLAB

Zai Lab

$18.33

0.47 (2.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVCR

Novocure

$43.90

-1.3 (-2.88%)

10:45
09/11/18
09/11
10:45
09/11/18
10:45
Conference/Events
Novocure has a conference call hosted by JPMorgan »

JPMorgan Analyst Kasimov…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

NVCR

Novocure

$45.20

-2 (-4.24%)

07:45
09/11/18
09/11
07:45
09/11/18
07:45
Conference/Events
Novocure has a conference call hosted by JPMorgan »

JPMorgan Analyst Kasimov…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

NVCR

Novocure

$45.35

2.3 (5.34%)

07:04
09/07/18
09/07
07:04
09/07/18
07:04
Recommendations
Novocure analyst commentary at Wedbush »

Novocure price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVCR

Novocure

$43.05

-1.9 (-4.23%)

08:32
09/06/18
09/06
08:32
09/06/18
08:32
Recommendations
Novocure analyst commentary at Wells Fargo »

Novocure price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

NVCR

Novocure

$43.05

-1.9 (-4.23%)

06:52
09/06/18
09/06
06:52
09/06/18
06:52
Recommendations
Novocure analyst commentary at Mizuho »

Novocure price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

NVCR

Novocure

$43.05

-1.9 (-4.23%)

17:08
09/05/18
09/05
17:08
09/05/18
17:08
Hot Stocks
Novocure announces extended overall survival in tumor treating fields trial »

Novocure announced final…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

Over a month ago
NVCR

Novocure

$36.85

-0.1 (-0.27%)

07:32
08/15/18
08/15
07:32
08/15/18
07:32
Hot Stocks
Novocure, US Oncology Research announce collaboration on PANOVA-3 trial »

Novocure and US Oncology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 05

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.